Targeting iHSP 70 in vitiligo: A critical step for cure?

Experimental Dermatology

Volumn 22, Issue 9, 2013, Pages 570-571

  Taïeb, Alain ^a   Seneschal, Julien ^a  

^a BORDEAUX UNIVERSITY HOSPITAL   (France)

Author keywords

Mouse models; Vitiligo

Indexed keywords

CORTICOSTEROID; CYCLOSPORIN; HEAT SHOCK PROTEIN 70; METHOTREXATE; TUMOR NECROSIS FACTOR ALPHA INHIBITOR; USTEKINUMAB;

GENE MUTATION; HUMAN; INFLAMMATION; KERATINOCYTE; LOW DRUG DOSE; MELANOCYTE; NOTE; PATHOPHYSIOLOGY; PHOTOTHERAPY; PROTEIN EXPRESSION; ULTRAVIOLET RADIATION; VITILIGO;

EID: 84882254492     PISSN: 09066705     EISSN: 16000625     Source Type: Journal    
DOI: 10.1111/exd.12202     Document Type: Note

References (9)

1. Mosenson J, Eby J, Hernandez C et al. Exp Dermatol 2013.
2. Picardo M, Taïeb A. Vitiligo. Heidelberg: Springer, 2010.
3. Ezzedine K, Lim H W, Suzuki T et al. Pigment Cell Melanoma Res 2012: 25: E1-E13.
4. Benson J M, Peritt D, Scallon B J et al. MAbs 2011: 3: 535-545.
5. Alghamdi K M, Khurrum H, Taieb A et al. J Drugs Dermatol 2012: 11: 534-539.
6. Taïeb A, Seneschal J, Mossalayi M D. J Dtsch Dermatol Ges 2012: 10: 174-187.
7. Wang D, Eiz-Vesper B, Zeitvogel J et al. Exp Dermatol 2011: 20: 637-641.
8. Fürnrohr B G, Wach S, Kelly J A et al. Ann Rheum Dis 2010: 69: 1983-1989.
9. Jonak C, Klosner G, Trautinger F. Front Biosci 2009: 14: 4758-4768.